LEAD TESTING DEFECT CHARGES

Medical device company to pay $42 million to resolve US lead-testing defect charges

Magellan, headquartered in Billerica, Massachusetts, agreed to plead guilty to two violations of the Food, Drug, and Cosmetic Act for failing to timely notify the FDA of the malfunction as part of a deal that calls for it to be sentenced to pay $32.7 million in fines and forfeitures.